https://www.selleckchem.com/pr....oducts/baricitinib-l
Twenty-five percent (19/77) of the samples obtained with 25G needles yielded a nondiagnostic cytology result (Bethesda category 1) as compared with 11% (8/7 in the 27G group ( = .0282; 95% CI, 1.47%-25.97%). On average, samples from 25G needles had a higher blood/fibrin quantitative score ( = .043; 95% CI, -0.64 to -0.01. There were no differences in pain between groups. Use of a 27G needle for fine-needle biopsies is not only safe and feasible but desirable and highly recommended, as it yields better diagnostic inform